Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nutritional drink aims to cut surgery complications in colorectal cancer

NCT ID NCT06134440

Disease control Sponsor: Istituto Oncologico Veneto IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a nutritional drink called Impact Oral®, taken for 5 days before and after surgery, could reduce complications in colorectal cancer patients. The trial included 71 patients eligible for minimally invasive surgery. However, the study was terminated early, so the results are not complete.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Impact Oral® (oral nutritional supplement with immune-nutrients)
What this could lead to
If it worked, this could show that a simple nutritional drink helps reduce complications after colorectal cancer surgery.
What could go wrong
The trial was terminated early, so results are limited. It only included patients eligible for minimally invasive surgery, so findings may not apply to all colorectal cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

71 people

The number who actually took part.

Started

Nov 2023

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged ≥ 18 years or older; * histologically confirmed adenocarcinoma of colon or rectum; * Eligible for elective curative surgery with indication of colon and/or rectal resection in laparoscopy with mini-invasive technique; * eligible for ERAS protocol; * Written informed consent to the study participation according to the Local Ethic Committee requirements before any study procedure; Exclusion Criteria: * colon or rectal resection for benign disease; * TNM Stage ≥4; * neoadjuvant radio and/or chemotherapy * ASA score \> 3; * contraindications to oral nutrition (e.g. dysphagia, pyloric stenosis) or hypersensitivity to any ingredient of study product; * albuminemia \< 3.0 g/l; * weight loss \> 10% in the last 3-6 months; * BMI \< 18.5 kg/m2; * pregnant or breastfeeding; * Not self-sufficient or with poor family compliance; * Congenital or acquired immunodeficiency; * Active uncontrolled pre-operative infections or other clinically relevant concomitant illness that preclude laparoscopic procedure; * Bowel obstruction or parenteral nutrition or gastric tube;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal adenocarcinoma

Contacts and locations

Locations

  • Istituto Oncologico Veneto IRCCS

    Padova, 35128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.